In a case report, a patient with microsatellite unstable high metastatic colorectal cancer treated with the combination of a PD-L1 antagonist and OX40 agonist showed pseudoprogression, with a 163% increase in the baseline tumor burden (Chae et al., 2017). Here, CD274 is linked to neoplasm.